2028, Food and Drug Administration, Marketing and Physicians

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2028

Food and Drug Administration

Marketing

Physicians

An increasing impact of BCMA-targeting biologics in multiple myeloma

Pharmaceutical Technology

SEPTEMBER 2, 2022

Multiple myeloma (MM) therapeutics comprise a multi-billion dollar market, among the most valuable in oncology. This is a result of intensive research efforts that have produced regimens that have prolonged patient survival, most of which are a combination of a proteasome inhibitor + an immunomodulatory drug (ie.

Food and Drug Administration

Food and Drug Administration FDA Sales Physicians

A history of blood cancer treatment

pharmaphorum

SEPTEMBER 13, 2022

Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. 2016–2022 — New treatments enter the market. 1832 – Discovery of Hodgkin’s and non-Hodgkin’s lymphoma.

Food and Drug Administration

Food and Drug Administration Patients Engineering Physicians

Pharma Rep Focus

An increasing impact of BCMA-targeting biologics in multiple myeloma

A history of blood cancer treatment

Stay Connected